en

PRODUCT DETAIL

Posakonazol Teva 100 mg gastrorezistentné tablety

Code 3012D
MA number 26/0376/19-S
Product Form: tbl ent 24x100 mg (blis.Al/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 26 - ANTIMYCOTICA (LOKÁLNE A CELKOVÉ)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J02 ANTIMYCOTICS FOR SYSTEMIC USE
J02A ANTIMYCOTICS FOR SYSTEMIC USE
J02AC Triazole and tetrazole derivatives
J02AC04 Posaconazole
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 04.12.2019
SPC: SPC_Posakonazol Teva_100 mg tbl ent_10.2022.pdf  
PIL: PIL_Posakonazol Teva 100 mg tbl ent_11.2023.pdf  
Safety feature Yes
Data update: 30.01.2024
eu-flag.png sk-flag.png